Author:Sciensus
Thought Leadership
Rare diseases
Market access for orphan drugs in Switzerland: a guide for US Biotechs
Blogs
Rare diseases
An introduction to PASS studies
Events
Rare diseases
Sciensus hosts a panel at the World Orphan Drug Congress 2024
News
Sciensus partners with Observia to improve medication adherence through behavioural insights
Thought Leadership
Unleashing valuable patient insights: The transformative power of patient reported data.
Events
Cancer
Clinical Pharmacy Congress 2024
Thought Leadership
Rare diseases
The impact of real-world data in gaining access to the European orphan drugs market
Thought Leadership
Long-term conditions
White Paper: Quality of Life
Events
Cancer
Reuters Pharma 2024 Conference